Senator calls on Biden to reject COVID IP waiver

Thom Tillis, ranking member of the senate IP subcommittee, has urged US president Joe Biden to oppose ‘harmful’ proposals to waive rights related to COVID-19 vaccines currently in discussions at the World Trade Organisation (WTO).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Activists urge Biden to champion temporary COVID-19 IP waiver

23 November 2021 Medical and human rights groups have called on US President Joe Biden to step up his personal engagement and help put in place a temporary waiver of IP rights for COVID-19 vaccines.

Americas

Former world leaders call on Biden to waive COVID IPs

15 April 2021 A group of more than 170 former world leaders and Nobel Laureates has called upon US President Joe Biden to waive IP rights for COVID vaccines, in an open letter posted yesterday.

Big Pharma

WHO head calls for IP waiver to beat COVID-19

9 March 2021 The director general of the World Health Organization has called for a waiver on IP rights to ensure more equitable access to COVID-19 vaccines.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Senator calls on Biden to reject COVID IP waiver

More on this story

Editor's picks

Editor's picks

More features